suPARnostic
suPAR as Predictor of Preoperative Risk Assessments
New abstract published in World Journal of Surgery;
"Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments" by Alstrup M et al.
New Employees at ViroGates
ViroGates is expanding and has welcomed 5 new employees since November 1, 2018.
The ViroGates team now includes 4 new members responsible for Sales and Business Development in Scandinavia, Germany, France and Spain, as well as an International Application Scientist.
Study combining suPAR and NEWS documents significantly improved risk stratification in Acute Medical patients
Data from a large observational study comprising 17,312 patients admitted at the Acute Medical Unit at Copenhagen University Hospital Amager and Hvidovre, Denmark has been published in the highly accredited medical journal Critical Care Medicine.
Results show that combining the National Early Warning Score (NEWS) with suPAR improves risk stratification significantly in acute medical patients.
Triage III study supports use of suPARnostic® in Emergency Departments
Data from the TRIAGE III study were presented at the 12th European Congress of Emergency Medicine in Glasgow, and shows that use of suPARnostic® Quick Triage shortened patients’ stay at Emergency Departments by 6.5 hours and allowed a significantly higher proportion of patients to be discharged within 24 hours.
